Season 1 Bonus
Narratives of PurposeApril 19, 2021x
11
00:21:1619.71 MB

Season 1 Bonus

On this final episode of Season one, I share some previously unreleased interview segments with five guests. There is Pauline Koelbl, founder of AfriProspect and ShEquity, who’s primary focus is African female-led innovative startups. Pauline tells me more about the first companies ShEquity has invested in. Then Ana Maria Angarita and Isabel Brücher, both co-founders of Capacity Zurich a talent and startup incubator for refugees and migrants in Switzerland. Ana Maria and Isabel share how Capacity actually started, what makes the diversity of its team, and which process to follow if you’re interested in becoming a volunteer mentor with their entrepreneurship program. There is also Thomas Bosshard, co-owner of Oertli Instrumente, a medical device company, who tells me how his collaboration with Dr. Sanduk Ruit (a world renowned eye surgeon from Nepal) has impacted his work and that of his employees. Finally, Alessandra Patti, founder of FindYourWay coaching and assertive communication lecturer, shares the importance of self-care during the current pandemic. 

 

Show Notes

If you want to follow these five guests on social media, here are their channels. Pauline Koelbl is on LinkedIn and TwitterAna Maria Angarita is on LinkedIn and Isabel Brücher is also on LinkedIn. Thomas Bosshard is on LinkedIn, Facebook, and Instagram. Alessandra Patti is on LinkedIn.

In case you wish to have more information on the organisations and companies mentioned in this episode, here are some useful links. These are the three first startups Pauline's venture ShEquity invested in: Superfluid labsWidenergy and Ecodudu. Ana Maria and Isabel spoke about their organisation Capacity Zurich. Oertli Insturmente AG co-owner, Thomas mentioned the documentary film "Out of the Darkness" featuring Dr. Ruit. Alessandra talked about how her coaching (FindYourWay coaching) and lecturing (University of St. Gallen) activities had been affected by the COVID-19 pandemic.